Dopamine reuptake by norepinephrine neurons: Exception or rule?

Critical Reviews in Neurobiology

Volumn 16, Issue 1-2, 2004, Pages 121-128

  Carboni, Ezio ^a   Silvagni, Alessandra ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dopamine; Microdialysis; Noradrenaline; Prefrontal cortex; Reuptake

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; COCAINE; DESIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; METHYLPHENIDATE; MIRTAZAPINE; NEUROLEPTIC AGENT; NORADRENALIN; REBOXETINE; VANOXERINE;

DOPAMINERGIC NERVE CELL; DRUG MECHANISM; HUMAN; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC NERVE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; REVIEW; STRIA TERMINALIS; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; NERVE ENDINGS; NERVE TISSUE PROTEINS; NEURONS; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; SUBSTANCE-RELATED DISORDERS;

EID: 9744277518     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v16.i12.130     Document Type: Review

References (39)

1. Andersen PH. (1989) The dopamine uptake inhibitor GBR 12909. Eur J Pharmacol 32:493-504.
2. Arnt J, Skarsfeldt T. (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101.
3. Berger B, Tassin JP, Blanc G, Moyne MA, Thierry AM. (1974) Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Res 81:332-7.
4. Berridge CW, Stratford TL, Jonson SE, Spealman RD. (1989) Distribution of dopamine beta-hydroxylase-like immunoreactibity fibers within the shell subregion of the nucleus accumbens. Synapse 27:230-41.
5. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW. (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711.
6. Carboni E, Imperato A, Perezzani L, Di Chiara G. (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653-61.
7. Carboni E, Tanda G, Frau R, Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1090.
8. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand m, Giros B and Di Chiara G. (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21:RC 141, 1-4.
9. Carboni E, Silvagni A, Valentini V, Di Chiara G. (2003) Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study. Neurosci Biobehav Rev 27:653-9.
10. Carboni E, Silvagni A, Vacca C, Di Chiara G. (2004) Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis, and prefrontal cortex. J Neurochem [submitted].
11. Carlsson A, Lindqvist M, Magnusson T. (1957) 3,4-Dihydroxyphenylananine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200.
12. Cass WA, Gerhardt GA. (1995) In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-7.
13. Chen JP, Ruan D, Paredes W, Gardner EL. (1992) Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Brain Res 571:235-41.
14. Devoto P, Flore G, Pani L, Gessa GL. (2001) Evidence for co-release of noeadrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-64.
15. Devoto P, Flore G, Vacca G, Pira L, Arca A, Casu MA, Pani L, Gessa GL. (2003) Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl). 167:79-84.
16. Devoto P, Flore G, Longu G, Pira L, Gessa GL. (2003) Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse 50:200-5.
17. Di Chiara G, Tanda G, Frau R, Carboni E. (1992) Heterologous monoamine reuptake: Lack of transmitter specificity of neuron-specific carriers. Neurochem Int 20:231s-5s.
18. Di Chiara G. (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137.
19. Giros B, Caron MG. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-9.
20. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-12.
21. Glowinsky J, Tassin JP and Therry. (1984) The mesocortico-prefrontal dopaminergic neurons. Trends Neurosci 7:415-8.
22. Kuhar MJ, Ritz MC, Boja JW. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
23. Lindvall O, Bjorklund A. (1978) Anatomy of the dopaminergic neuron systems in the rat brain. Adv Biochem Psychopharmacol 19:1-23.
24. Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas JP, Lejeune F. (2000) Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci 12:1079-95.
25. Moghaddam B. (1994) Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance. J Clin Psychiatry 55 Suppl B:27-9.
26. Phelix CF, Liposits Z, Paull WK. (1994) Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull 33:109-19.
27. Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R. (1994). Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem 63:195-200.
28. Raiteri M, Dek, Carmine R., Bertolini A, Levi G. (1977) Effects of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41:133-43.
29. Rocha BA, Fumagalli, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. (1998) Cocaine self-administration in dopamine-transporter knock-out mice. Nat Neurosci 1:132-7.
30. Sagvolden T, Sergeant JA. (1998) Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 94:1-10.
31. Sora I, Wichems C, Takahasci N, Li X-F, Zeng Z, Revay R, Lesch KL, Murphy DL, Uhl GR. (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 9:7699-704.
32. Tanda G, Pontieri FE, Frau R, Di Chiara G. (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-85.
33. Thierry AM, Blanc G, Sobel A, Stinus L, Golwinski J. (1979) Dopaminergic terminals in the rat cortex. Science 182:499-501.
34. Valentini V, Frau R, Di Chiara G. (2004) Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J Neurochem 88:917-27.
35. th Ed. Siegel GJ, Agranoff BW, Wayne R, Molinoff BP Eds. Raven Press New York. 261-81.
36. Wong EHF, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Ranklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA. (2000) Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47:818-29.
37. Westerink BH, de Boer P, de Vries JB, Kruse CG, Long SK. (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol 361:27-33.
38. Westerink BH, Kawahara Y, De Boer P, Geels C, De Vries JB, Wikstrom HV, Van Kalkeren A, Van Vliet B, Kruse CG, Long SK. (2001) Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 412:127-38.
39. Yamamoto BK, Novotney S. (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71:274-80.